Suppressors of the malignant phenotype

Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear similar.

Journal of radiation oncology·2016

IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Oncogene·2015

Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.

Oncogene·2014

EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.

Oncogene·2013

Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

AJNR. American journal of neuroradiology·2012

Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Current cancer drug targets·2012

Early changes in intramitochondrial cardiolipin distribution during apoptosis.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·2002

Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·2002

Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·2002

Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·2002

Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·2002

Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research·2002

Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial design.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Efficacy and safety of carboplatin-containing chemotherapy in triple-negative breast cancer: A comprehensive systematic review, meta-analysis, and trial sequential analysis with BRCA/HRD subgroup assessment.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Roles of TIR domain-containing adaptor protein in tumor: Inflammation and immune regulation via toll-like receptor signaling.

The Journal of international medical research·2026

Related Experiment Videos

Suppressors of the malignant phenotype

Related Concept Videos

Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear similar.

IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.

EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.

Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study.

Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Early changes in intramitochondrial cardiolipin distribution during apoptosis.

Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.

Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes.

Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).

Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.

Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial design.

Efficacy and safety of carboplatin-containing chemotherapy in triple-negative breast cancer: A comprehensive systematic review, meta-analysis, and trial sequential analysis with BRCA/HRD subgroup assessment.

Roles of TIR domain-containing adaptor protein in tumor: Inflammation and immune regulation via toll-like receptor signaling.

Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger.

The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation.

High-Resolution Mass Spectrometric Analysis of Selected DNA Adducts in Smokeless Tobacco Users' Oral Cells.

Related Experiment Videos

Suppressors of the malignant phenotype

Related Concept Videos

Related Articles